Johnson Pharmacare Limited submitted a regulatory disclosure to BSE Limited regarding related party transactions for the period ended March 31, 2026. The disclosure is made pursuant to Regulation 23(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and follows the format specified in SEBI Circular No. SEBI/HO/CFD/CMD1/CIR/P/2021/662 dated November 22, 2021.
The company confirmed that while related party transaction provisions are applicable to the company, it did not enter into any transactions with related parties as defined under applicable accounting standards and SEBI regulations during the reporting period ended March 31, 2026.
A detailed nil return table was provided showing:
- No transactions occurred during the reporting period
- Opening balance: NIL
- Closing balance: NIL
- No financial indebtedness was incurred
- All fields including nature of indebtedness, tenure, interest rate, security status, and purpose of funds were marked as "-" or "NIL"
The disclosure was signed by Nand Kishor Ray, Additional Director (DIN: 11626638) on behalf of the Board of Directors from Delhi. The digital signature was timestamped May 27, 2026 at 19:22:40 IST.
Financial Impact
No financial impact - the company reported zero related party transactions during the reporting period.